These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33636339)

  • 1. Interpreting Burkholderia pseudomallei disc diffusion susceptibility test results by the EUCAST method.
    Dance DAB; Wuthiekanun V; Baird RW; Norton R; Limmathurotsakul D; Currie BJ
    Clin Microbiol Infect; 2021 Jun; 27(6):827-829. PubMed ID: 33636339
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
    Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
    Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.
    Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE
    Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.
    Liew FY; Tay ST; Puthucheary SD
    Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
    Dutta S; Haq S; Hasan MR; Haq JA
    BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
    Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
    Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
    J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
    Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Ceftolozane-Tazobactam against
    Slack A; Parsonson F; Cronin K; Engler C; Norton R
    Am J Trop Med Hyg; 2018 Aug; 99(2):281-282. PubMed ID: 29943711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
    Sivalingam SP; Sim SH; Aw LT; Ooi EE
    J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials.
    Sam IC; See KH; Puthucheary SD
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):308-9. PubMed ID: 20356698
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of biapenem against Burkholderia pseudomallei.
    Thamlikitkul V; Trakulsomboon S
    Int J Antimicrob Agents; 2010 May; 35(5):514. PubMed ID: 20188524
    [No Abstract]   [Full Text] [Related]  

  • 16. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
    Wuthiekanun V; Cheng AC; Chierakul W; Amornchai P; Limmathurotsakul D; Chaowagul W; Simpson AJ; Short JM; Wongsuvan G; Maharjan B; White NJ; Peacock SJ
    J Antimicrob Chemother; 2005 Jun; 55(6):1029-31. PubMed ID: 15886263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies.
    Smith MD; Wuthiekanun V; Walsh AL; White NJ
    J Antimicrob Chemother; 1994 Jan; 33(1):145-9. PubMed ID: 7512547
    [No Abstract]   [Full Text] [Related]  

  • 20. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
    Karunakaran R; Puthucheary SD
    Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.